Osteoporosis Treatment Market Growth Analysis With Investment Opportunities

July 09, 2024 09:12 PM AEST | By EIN Presswire
 Osteoporosis Treatment Market Growth Analysis With Investment Opportunities
Image source: EIN Presswire

LONDON, GREATER LONDON , UK, July 9, 2024 /EINPresswire.com/ -- The global osteoporosis treatment market has exhibited robust growth in recent years, driven by advancements in medical interventions aimed at managing and improving the condition of osteoporosis. Osteoporosis, characterized by a decline in bone mass and mineral density, poses significant healthcare challenges worldwide.

Market Size and Growth Drivers
The osteoporosis treatment market size is poised to grow from $13.16 billion in 2023 to $13.87 billion in 2024, reflecting a compound annual growth rate (CAGR) of 5.3%. This growth is attributed to factors such as an aging population demographic, increased adoption of hormone replacement therapies, calcium and vitamin D supplementation, and enhanced diagnostic tools. Moving forward, the market is expected to continue expanding, reaching $16.6 billion by 2028 at a CAGR of 4.6%. Factors fueling this growth include rising sedentary lifestyles, an increasing prevalence of secondary osteoporosis, the emergence of virtual bone fracture clinics, advancements in gene therapy, and a heightened focus on men's bone health.

Explore comprehensive insights into the global osteoporosis treatment market with a detailed sample report: https://www.thebusinessresearchcompany.com/sample_request?id=12166&type=smp

Osteoporosis Treatment Market Major Players and Market Trends
Key companies driving innovation in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, and others. These players focus on developing derivative capsules such as vitamin D3 derivatives to gain a competitive edge. For instance, Chugai Pharmaceutical Co., Ltd. launched 'Edirol Tablets 0.5 µg/0.75 µg' in partnership with Towa Pharmaceutical, aimed at enhancing bone and calcium metabolism in osteoporosis patients.

Osteoporosis Treatment Market Segments
The osteoporosis treatment market is segmented based on:
• Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor
• Route of Administration: Oral, Injectable, Other Routes
• Distribution Channel: Hospitals, Retail Pharmacies and Stores, Online Pharmacies

Regional Insights
North America dominated the osteoporosis treatment market in 2023, driven by advanced healthcare infrastructure and high awareness. Asia-Pacific is anticipated to be the fastest-growing region during the forecast period, owing to rising healthcare expenditures and increasing awareness about bone health.

Full Report CTA
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

Osteoporosis Treatment Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Osteoporosis Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on osteoporosis treatment market size, osteoporosis treatment market drivers and trends, osteoporosis treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The osteoporosis treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Sewage Treatment Facilities Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/sewage-treatment-facilities-global-market-report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

Wastewater Treatment Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/wastewater-treatment-equipment-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.